Tag: Brad Loncar

Biotech Expert Brad Loncar on Cancer Immunotherapy, Biotech ETFs

Brad Loncar, biotech expert & CEO of Loncar Investments, discusses the latest in cancer immunotherapy and highlights the index behind the Loncar Cancer Immunotherapy ETF (CNCR).  Brad also offers insight into the broader biotech sector, including the three largest biotech ETFs.

Biotech Expert Brad Loncar on Cancer Immunotherapy, Biotech ETFs

Brad Loncar, biotech expert & CEO of Loncar Investments, discusses the latest in cancer immunotherapy and highlights the index behind the Loncar Cancer Immunotherapy ETF (CNCR).  Brad also offers insight into the broader biotech sector, including the three largest biotech ETFs.

Biotech Expert Brad Loncar Discusses Sector, ETFs

Biotech industry expert Brad Loncar discusses his approach to investing in biotech stocks and key current drivers in the sector.  Brad also offers his perspective on broad-based biotech ETFs and explains the index behind the Loncar Cancer Immunotherapy ETF (CNCR).

Biotech Expert Brad Loncar Discusses Sector, ETFs

Biotech industry expert Brad Loncar discusses his approach to investing in biotech stocks and key current drivers in the sector.  Brad also offers his perspective on broad-based biotech ETFs and explains the index behind the Loncar Cancer Immunotherapy ETF (CNCR).  Nate & Jason spotlight the First Trust NYSE Arca Biotechnology Index Fund (FBT).

Brad Loncar Spotlights Cancer Immunotherapy Index

Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment.

Biotech ETFs in Focus

Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment.  Nate and Conor also explain why ETFs can be an excellent way to access the biotech space in general.